Financhill
Sell
15

TLS Quote, Financials, Valuation and Earnings

Last price:
$1.98
Seasonality move :
11.37%
Day range:
$1.83 - $2.64
52-week range:
$1.83 - $5.03
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.30x
P/B ratio:
1.15x
Volume:
12.3M
Avg. volume:
919.5K
1-year change:
-42.01%
Market cap:
$146.7M
Revenue:
$108.3M
EPS (TTM):
-$0.73

Earnings Data

Next earnings date for TLS
Aug 08
2025
Most recent earnings per share
-$0.13
Missed by $0.04
(Mar 10/2025)
Consensus Estimate
-$0.09
(Mar 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TLS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/08/2025 Q2 $32.8M -- -- -$0.05 --
05/09/2025 Q1 $29.2M -- -- -$0.05 --
03/10/2025 Q4 $25.5M $26.4M -$0.13 -$0.09 -$0.04
11/12/2024 Q3 $23M $23.8M -$0.39 -$0.14 -$0.25
08/09/2024 Q2 $26.5M $28.5M -$0.11 -$0.14 $0.03
05/10/2024 Q1 $28.5M $29.6M -$0.10 -$0.11 $0.01
03/15/2024 Q4 $32.1M $41.1M -$0.10 -$0.11 $0.01
11/09/2023 Q3 $32M $36.2M -$0.12 -$0.13 $0.01
08/09/2023 Q2 $29.8M $32.9M -$0.12 -$0.13 $0.01
05/10/2023 Q1 $31.2M $35.2M -$0.16 -$0.13 -$0.03
03/16/2023 Q4 $44.8M $47.3M -$0.21 -$0.01 -$0.20
11/09/2022 Q3 -- $63.6M -$0.13 -- --
08/09/2022 Q2 -- $55.8M -$0.21 -- --
05/10/2022 Q1 -- $50.2M -$0.25 -- --
03/01/2022 Q4 -- $64.1M -$0.08 -- --
11/15/2021 Q3 -- $69M -$0.08 -- --
08/16/2021 Q2 -- $53.6M -$0.26 -- --
05/17/2021 Q1 -- $55.8M -$0.23 -- --
03/04/2021 Q4 -- $44.9M $0.06 -- --
09/30/2020 Q3 -- $47.4M -$0.00 -- --
06/30/2020 Q2 -- $48.6M $0.01 -- --
03/31/2020 Q1 -- $39M -$0.05 -- --
12/31/2019 Q4 -- $46.5M -$0.07 -- --
09/30/2019 Q3 -- $45.5M $0.05 -- --
06/30/2019 Q2 -- $36M -$0.04 -- --
03/31/2019 Q1 -- $31.2M -$0.07 -- --
12/31/2018 Q4 -- $36M -$0.07 -- --
09/30/2018 Q3 -- $34.7M $0.08 -- --
06/30/2018 Q2 -- $34.9M -$0.00 -- --
03/31/2018 Q1 -- $32.4M -$0.04 -- --
12/31/2017 Q4 -- $35.3M $0.08 -- --
09/30/2017 Q3 -- $28.2M -$0.06 -- --
06/30/2017 Q2 -- $21.1M -$0.08 -- --
03/31/2017 Q1 -- $23.1M -$0.07 -- --
12/31/2016 Q4 -- $26.1M -$0.10 -- --
09/30/2016 Q3 -- $54.9M -$0.00 -- --
06/30/2016 Q2 -- $26.8M -$0.04 -- --
03/31/2016 Q1 -- $27.1M -$0.02 -- --
12/31/2015 Q4 -- $26.9M -$0.21 -- --
09/30/2015 Q3 -- $33.7M -$0.03 -- --
06/30/2015 Q2 -- $32M -$0.05 -- --

Telos Earnings Questions

  • How Much did Telos Generate in Revenue Last Quarter?

    Telos reported $26.4M worth of top line sales in its most recent quarter.

  • Did Telos Beat Earnings Last Quarter?

    Telos announced earnings per share of -$0.13 which represents a miss of analyst forecast a -$0.09 per share.

  • Is Telos Profitable?

    Telos reported $10.6M that represents $0.15 per share over the last quarter.

  • What is the Analyst Consensus for Telos EPS Next Year?

    Telos's earnings are forecast to decrease from -$0.73 per share to -$0.36 per share next year representing a decrease of -81.1%.

  • When is Telos's Earnings Date?

    Telos's next earnings date is August 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Spotify a Millionaire-Maker Stock?
Is Spotify a Millionaire-Maker Stock?

Spotify (NYSE:SPOT) may seem like an expensive proposition trading closer…

What Is a Millionaire-Maker Stock?
What Is a Millionaire-Maker Stock?

From time to time, investors will run across the term…

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 40x

Alerts

Buy
60
RGC alert for May 10

Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.

Buy
97
NGVC alert for May 10

Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.

Sell
38
ONTO alert for May 10

Onto Innovation [ONTO] is down 30.17% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock